There are concerns about the use of GLP-1 medications, particularly regarding stopping and restarting treatment. Some patients may be forced to stop due to restrictions on coverage, while others may consider stopping due to potential complications, such as a complicated relationship with eating disorders. The safety and recommendations surrounding stopping and restarting GLP-1 medications are being discussed by experts, with some emphasizing the need for an exit plan.